Genetic biomarkers are specific genes or mutations associated with cancer. They can be used to predict disease risk, diagnose cancer, and guide treatment decisions. For instance, the presence of BRCA1 and BRCA2 mutations increases the risk of breast and ovarian cancers. Identifying such biomarkers helps in early detection and personalized treatment, improving patient outcomes.
